Davis Capital Management’s AbbVie ABBV Stock Holding History

Davis Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Sell	5,302 -24	-0.5%	-$5.16K	0.79%	36
2026 Q1	$1.16M	Sell	5,326 -22	-0.4%	-$4.88K	0.79%	39
2025 Q4	$1.22M	Sell	5,348 -28	-0.5%	-$6.38K	0.84%	36
2025 Q3	$1.24M	Buy	+5,376	New	+$1.09M	0.86%	37
2025 Q1	$1.13M	Sell	5,382 -109	-2%	-$21.2K	0.9%	34
2024 Q4	$976K	Sell	5,491 -119	-2%	-$21.9K	0.79%	38
2024 Q3	$1.11M	Sell	5,610 -75	-1%	-$14K	0.88%	37
2024 Q2	$969K	Sell	5,685 -41	-0.7%	-$6.79K	0.84%	37
2024 Q1	$1.04M	Sell	5,726 -88	-2%	-$15.2K	0.92%	39
2023 Q4	$901K	Buy	+5,814	New	+$848K	0.86%	40
2020 Q2	$702K	Sell	7,155 -152	-2%	-$13.4K	1.3%	31
2020 Q1	$557K	Buy	+7,307	New	+$622K	1.18%	35

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Davis Capital Management's ABBV Position: Q2 2026 in Review

Davis Capital Management reduced its AbbVie (ABBV) stake by 0.45% in Q2 2026, selling an estimated $5.16K and leaving 5,302 shares worth $1.33M. The position accounts for 0.79% of the portfolio, ranked #36.

Davis Capital Management first reported a position in ABBV in Q1 2020 and has held it in 12 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Davis Capital Management held 5,302 shares of AbbVie worth $1.33M as of Q2 2026.
Davis Capital Management sold 24 AbbVie shares in Q2 2026, an estimated $5.16K.
AbbVie made up 0.79% of Davis Capital Management's portfolio in Q2 2026, its #36 holding.
Davis Capital Management first reported a position in AbbVie in Q1 2020 and has held it in 12 quarters since.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.